Oxidative Stress and Erectile Dysfunction: Pathophysiology, Impacts, and Potential Treatments
Authors:
- Aris KaltsasAris Kaltsas
- Athanasios ZikopoulosAZAthanasios Zikopoulos
- Fotios DimitriadisFotios Dimitriadis
- Danja SheshiDSDanja Sheshi
- Magdalena PolitisMPMagdalena Politis
- Efthalia MoustakliEMEfthalia Moustakli
- Evangelos N. SymeonidisEvangelos N. Symeonidis
- Michael ChrisofosMCMichael Chrisofos
- Nikolaos SofikitisNSNikolaos Sofikitis
- Athanasios ZachariouAthanasios Zachariou
Top Cited Papers
Open Access
- 14 August 2024
- journal article
- review article
- Published by MDPI AG in Current Issues in Molecular Biology
- Vol. 46 (8) , 8807-8834
Abstract
Erectile dysfunction (ED) is a prevalent condition affecting men’s sexual health, with oxidative stress (OS) having recently been identified as a significant contributing causative factor. This narrative review aims to elucidate the role of OS in the pathophysiology of ED, focusing on impact, mechanisms, and potential therapeutic interventions. Key findings indicate that OS disrupts endothelial function and nitric oxide (NO) signaling, crucial for erectile function. Various sources of reactive oxygen species (ROS) and their detrimental effects on penile tissue are discussed, including aging, diabetes mellitus, hypertension, hyperlipidemia, smoking, obesity, alcohol consumption, psychological stress, hyperhomocysteinemia, chronic kidney disease, and sickle cell disease. Major sources of ROS, such as NADPH oxidase, xanthine oxidase, uncoupled endothelial NO synthase (eNOS), and mitochondrial electron transport, are identified. NO is scavenged by these ROS, leading to endothelial dysfunction characterized by reduced NO availability, impaired vasodilation, increased vascular tone, and inflammation. This ultimately results in ED due to decreased blood flow to penile tissue and the inability to achieve or maintain an erection. Furthermore, ROS impact the transmission of nitrergic neurotransmitters by causing the death of nitrergic neurons and reducing the signaling of neuronal NO synthase (nNOS), exacerbating ED. Therapeutic approaches targeting OS, including antioxidants and lifestyle modifications, show promise in ameliorating ED symptoms. The review underscores the need for further research to develop effective treatments, emphasizing the interplay between OS and vascular health in ED. Integrating pharmacological and non-pharmacological strategies could enhance clinical outcomes for ED patients, advocating for OS management in ED treatment protocols to improve patient quality of life.Keywords
This publication has 237 references indexed in Scilit:
- Efficacy and safety of oral phosphodiesterase 5 inhibitors for erectile dysfunction: a network meta-analysis and multicriteria decision analysisWorld Journal of Urology, 2020
- Treatments for priapism in boys and men with sickle cell diseaseCochrane Database of Systematic Reviews, 2020
- Role of oxidative stress in the pathogenesis of sickle cell diseaseIUBMB Life, 2011
- Some enzymatic/nonenzymatic antioxidants as potential stress biomarkers of trichloroethylene, heavy metal mixture, and ethyl alcohol in rat tissuesEnvironmental Toxicology, 2011
- Vasculopathy in sickle cell disease: Biology, pathophysiology, genetics, translational medicine, and new research directionsAmerican Journal of Hematology, 2009
- Antioxidative effects of statinsArchives of Toxicology, 2008
- Restoration of Erectile Capacity in Normotensive Aged Rats by Modulation of Angiotensin Receptor Type 1Journal of Andrology, 2005
- Oxidative Stress and Antioxidant Therapy: Their Impact in Diabetes‐Associated Erectile DysfunctionJournal of Andrology, 2004
- Synergistic action of advanced glycation end products and endogenous nitric oxide leads to neuronal apoptosis in vitro: A new insight into selective nitrergic neuropathy in diabetesDiabetologia, 2003
- Involvement of superoxide radical in the impaired endothelium-dependent relaxation of cavernous smooth muscle in hypercholesterolemic rabbitsUrological Research, 1997